{"transactions":[{"id":4638352,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":29375,"kind":"person","name":"Werner Sean","position":1,"cik":"0002047541","reported_name":"Werner Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2026-10-09T01:54:36.000Z","date":"2026-10-06","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":69979,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects the disposition of shares of common stock (\"Common Stock\") of BioLife Solutions, Inc. (the \"Registrant\") in connection with the consummation on October 6, 2026 of the merger of Bravo Merger Sub I, Inc., a Delaware corporation (\"Merger Sub 1\") with and into the Registrant (the \"First Merger\"), pursuant to the Agreement and Plan of Merger, dated as of July 21, 2026 (the \"Merger Agreement\"), by and among the Registrant, Repligen Corporation, a Delaware corporation (\"Repligen\"), Merger Sub 1 and Bravo Merger Sub II, LLC, a Delaware limited liability company. At the effective time of the First Merger (the \"First Merger Effective Time\"), each outstanding share of Common Stock was converted into the right to receive $11.25 in cash and 0.1442 shares of Repligen common stock, in each case subject to the terms and conditions of the Merger Agreement."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193125-26-418304","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/2047541/000119312526418304/ownership.xml","form_type":"4"}},{"id":4638351,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":29375,"kind":"person","name":"Werner Sean","position":1,"cik":"0002047541","reported_name":"Werner Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2026-10-09T01:54:36.000Z","date":"2026-10-06","kind":"tax_withholding","planned":false,"acquired":false,"shares":71226,"price":38.61,"value":2750035.86,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents shares withheld to cover tax withholding obligations in connection with the vesting of the market-based restricted stock award."}],"balance_after":24039,"source":{"system":"sec-edgar","filing":"0001193125-26-418304","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2047541/000119312526418304/ownership.xml","form_type":"4"}},{"id":4638350,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":29375,"kind":"person","name":"Werner Sean","position":1,"cik":"0002047541","reported_name":"Werner Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2026-10-09T01:54:36.000Z","date":"2026-10-06","kind":"grant","planned":false,"acquired":true,"shares":48232,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The restricted stock was granted pursuant to the 2023 Plan. In accordance with the terms of the grant and the Merger Agreement, the restricted stock vested immediately prior to the First Merger Effective Time as to approximately 200% of the number of shares granted based on the Registrant's total shareholder return during the period beginning on January 1, 2026 through October 2, 2026 as compared to the total shareholder return of certain of the Registrant's peers (such peers have been determined by the Registrant's compensation committee with assistance of an outside consultant immediately prior to the grant date)."}],"balance_after":95265,"source":{"system":"sec-edgar","filing":"0001193125-26-418304","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2047541/000119312526418304/ownership.xml","form_type":"4"}},{"id":4638349,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":29375,"kind":"person","name":"Werner Sean","position":1,"cik":"0002047541","reported_name":"Werner Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2026-10-09T01:54:36.000Z","date":"2026-10-06","kind":"grant","planned":false,"acquired":true,"shares":45838,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The restricted stock was granted pursuant to the BioLife Solutions 2023 Omnibus Performance Incentive Plan (the \"2023 Plan\"). In accordance with the terms of the grant and the Merger Agreement, the restricted stock vested immediately prior to the First Merger Effective Time as to approximately 200% of the number of shares granted based on the Registrant's total shareholder return during the period beginning on January 1, 2025 through October 2, 2026 as compared to the total shareholder return of certain of the Registrant's peers (such peers have been determined by the Registrant's compensation committee with assistance of an outside consultant immediately prior to the grant date)."}],"balance_after":47033,"source":{"system":"sec-edgar","filing":"0001193125-26-418304","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2047541/000119312526418304/ownership.xml","form_type":"4"}},{"id":4624846,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":29375,"kind":"person","name":"Werner Sean","position":1,"cik":"0002047541","reported_name":"Werner Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2026-09-22T21:11:47.000Z","date":"2026-09-18","kind":"tax_withholding","planned":false,"acquired":false,"shares":421,"price":36.69,"value":15446.49,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of restricted stock units."}],"balance_after":47135,"source":{"system":"sec-edgar","filing":"0001628280-26-063077","document":"wk-form4_1790111504.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2047541/000162828026063077/wk-form4_1790111504.xml","form_type":"4"}},{"id":705391,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":29375,"kind":"person","name":"Werner Sean","position":1,"cik":"0002047541","reported_name":"Werner Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2026-07-21T22:47:39.000Z","date":"2026-07-17","kind":"tax_withholding","planned":false,"acquired":false,"shares":275,"price":29.15,"value":8016.25,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of restricted stock units."}],"balance_after":47556,"source":{"system":"sec-edgar","filing":"0001628280-26-049086","document":"wk-form4_1784674056.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828026049086/wk-form4_1784674056.xml","form_type":"4"}},{"id":731239,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":29375,"kind":"person","name":"Werner Sean","position":1,"cik":"0002047541","reported_name":"Werner Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2026-06-22T20:50:26.000Z","date":"2026-06-18","kind":"tax_withholding","planned":false,"acquired":false,"shares":420,"price":26.04,"value":10936.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of restricted stock units."}],"balance_after":47831,"source":{"system":"sec-edgar","filing":"0001628280-26-044698","document":"wk-form4_1782161424.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828026044698/wk-form4_1782161424.xml","form_type":"4"}},{"id":831554,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":29375,"kind":"person","name":"Werner Sean","position":1,"cik":"0002047541","reported_name":"Werner Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2026-03-23T21:08:55.000Z","date":"2026-03-19","kind":"tax_withholding","planned":false,"acquired":false,"shares":1681,"price":19.12,"value":32140.72,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of restricted stock units."}],"balance_after":48251,"source":{"system":"sec-edgar","filing":"0001628280-26-020579","document":"wk-form4_1774300132.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828026020579/wk-form4_1774300132.xml","form_type":"4"}},{"id":859866,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":29375,"kind":"person","name":"Werner Sean","position":1,"cik":"0002047541","reported_name":"Werner Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2026-03-05T22:10:35.000Z","date":"2026-03-03","kind":"sale","planned":true,"acquired":false,"shares":111,"price":20.74,"value":2302.14,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-24-2022 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":49932,"source":{"system":"sec-edgar","filing":"0001628280-26-015342","document":"wk-form4_1772748632.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828026015342/wk-form4_1772748632.xml","form_type":"4"}},{"id":880777,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":29375,"kind":"person","name":"Werner Sean","position":1,"cik":"0002047541","reported_name":"Werner Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2026-02-26T22:55:23.000Z","date":"2026-02-24","kind":"grant","planned":false,"acquired":true,"shares":24116,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The restricted stock was granted pursuant to the BioLife Solutions 2023 Omnibus Performance Incentive Plan and vests 25% on the first anniversary of the grant date and thereafter quarterly, in 12 equal quarterly installments. The restricted stock was granted to the reporting person as part of 2026 compensation."}],"balance_after":50043,"source":{"system":"sec-edgar","filing":"0001628280-26-012471","document":"wk-form4_1772146521.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828026012471/wk-form4_1772146521.xml","form_type":"4"}},{"id":986395,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":29375,"kind":"person","name":"Werner Sean","position":1,"cik":"0002047541","reported_name":"Werner Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2025-11-28T22:35:17.000Z","date":"2025-11-25","kind":"sale","planned":true,"acquired":false,"shares":110,"price":26.74,"value":2941.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-24-2022 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":25927,"source":{"system":"sec-edgar","filing":"0001628280-25-054279","document":"wk-form4_1764369314.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828025054279/wk-form4_1764369314.xml","form_type":"4"}},{"id":1015004,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":29375,"kind":"person","name":"Werner Sean","position":1,"cik":"0002047541","reported_name":"Werner Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2025-10-22T21:02:40.000Z","date":"2025-10-20","kind":"sale","planned":true,"acquired":false,"shares":275,"price":27.82,"value":7650.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 07-17-2024 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":26037,"source":{"system":"sec-edgar","filing":"0001628280-25-045913","document":"wk-form4_1761166957.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828025045913/wk-form4_1761166957.xml","form_type":"4"}},{"id":1041000,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":29375,"kind":"person","name":"Werner Sean","position":1,"cik":"0002047541","reported_name":"Werner Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2025-09-15T21:01:54.000Z","date":"2025-09-11","kind":"sale","planned":true,"acquired":false,"shares":72,"price":26.83,"value":1931.76,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 09-01-2021 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":26312,"source":{"system":"sec-edgar","filing":"0002047541-25-000003","document":"wk-form4_1757970111.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000204754125000003/wk-form4_1757970111.xml","form_type":"4"}},{"id":1054155,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":29375,"kind":"person","name":"Werner Sean","position":1,"cik":"0002047541","reported_name":"Werner Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2025-08-28T21:07:19.000Z","date":"2025-08-26","kind":"sale","planned":true,"acquired":false,"shares":111,"price":25.44,"value":2823.84,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-24-2022 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":26384,"source":{"system":"sec-edgar","filing":"0001628280-25-041302","document":"wk-form4_1756415234.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828025041302/wk-form4_1756415234.xml","form_type":"4"}},{"id":1083659,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":29375,"kind":"person","name":"Werner Sean","position":1,"cik":"0002047541","reported_name":"Werner Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2025-07-22T21:33:30.000Z","date":"2025-07-18","kind":"sale","planned":true,"acquired":false,"shares":1115,"price":21.22,"value":23660.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 07-17-2024 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":26495,"source":{"system":"sec-edgar","filing":"0001628280-25-035591","document":"wk-form4_1753220003.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828025035591/wk-form4_1753220003.xml","form_type":"4"}},{"id":1114244,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":29375,"kind":"person","name":"Werner Sean","position":1,"cik":"0002047541","reported_name":"Werner Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2025-06-12T21:24:08.000Z","date":"2025-06-10","kind":"sale","planned":true,"acquired":false,"shares":65,"price":23.7,"value":1540.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 09-01-2021 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":27610,"source":{"system":"sec-edgar","filing":"0001628280-25-031100","document":"wk-form4_1749763442.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828025031100/wk-form4_1749763442.xml","form_type":"4"}},{"id":1129931,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":29375,"kind":"person","name":"Werner Sean","position":1,"cik":"0002047541","reported_name":"Werner Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2025-05-30T21:57:12.000Z","date":"2025-05-28","kind":"sale","planned":true,"acquired":false,"shares":109,"price":22.46,"value":2448.14,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-24-2022 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":27675,"source":{"system":"sec-edgar","filing":"0001628280-25-028695","document":"wk-form4_1748642210.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828025028695/wk-form4_1748642210.xml","form_type":"4"}},{"id":1196269,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":29375,"kind":"person","name":"Werner Sean","position":1,"cik":"0002047541","reported_name":"Werner Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2025-03-20T23:07:37.000Z","date":"2025-03-18","kind":"grant","planned":false,"acquired":true,"shares":22919,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The restricted stock was granted pursuant to the BioLife Solutions 2023 Omnibus Performance Incentive Plan (the \"2023 Plan\") and vests 25% on the first anniversary of the grant date and thereafter quarterly, in 12 equal quarterly installments. The restricted stock was granted to the reporting person as part of 2025 compensation."}],"balance_after":27784,"source":{"system":"sec-edgar","filing":"0001628280-25-014180","document":"wk-form4_1742512051.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828025014180/wk-form4_1742512051.xml","form_type":"4"}},{"id":1224609,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":29375,"kind":"person","name":"Werner Sean","position":1,"cik":"0002047541","reported_name":"Werner Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2025-03-05T22:14:01.000Z","date":"2025-03-04","kind":"sale","planned":true,"acquired":false,"shares":88,"price":24.03,"value":2114.64,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 09-01-2021 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":4865,"source":{"system":"sec-edgar","filing":"0001628280-25-010568","document":"wk-form4_1741212833.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828025010568/wk-form4_1741212833.xml","form_type":"4"}},{"id":1224608,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":29375,"kind":"person","name":"Werner Sean","position":1,"cik":"0002047541","reported_name":"Werner Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2025-03-05T22:14:01.000Z","date":"2025-03-03","kind":"sale","planned":true,"acquired":false,"shares":136,"price":25.46,"value":3462.56,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-24-2022 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":4953,"source":{"system":"sec-edgar","filing":"0001628280-25-010568","document":"wk-form4_1741212833.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828025010568/wk-form4_1741212833.xml","form_type":"4"}}]}